Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion type Assertion NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_head.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion description "[In this study, we evaluated the ability of anti-p21 antibodies conjugated to 17-mer peptides [GRKKRRQRRRPPQGYGC] harboring the membrane-translocating and nuclear import sequences [underlined] of HIV-1 tat protein to inhibit the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1) (p21) and differentially sensitize MDA-MB-468 and MCF-7 human breast cancer (BC) cells to the antiproliferative effects of treatments that induce or do not induce p21.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_provenance.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion evidence source_evidence_literature NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_provenance.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion SIO_000772 16984139 NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_provenance.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion wasDerivedFrom befree-20140225 NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_provenance.
- NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_assertion wasGeneratedBy ECO_0000203 NP784316.RA9UaP0FAoIssNgyUIM7Gf1O6c2_4UNZkTOEx-zIMqiXk130_provenance.